Skip to main content
. 2022 Jun 22;12:911259. doi: 10.3389/fcimb.2022.911259

Figure 4.

Figure 4

GW4064 treatment did not alter exploratory locomotion and anxiety in the open field test. (A) The representative traces of different groups of mice in the open field test. (B) The activity was measured as the total amount of distance traveled. The BTBR mice showed a stronger exploratory locomotion ability than C57 mice. (D) BTBR mice spent less time in the center in the open field test, and the total time of the 30-minute test in the center was not affected by GW4064 treatment in C57 and BTBR mice. (C, E) A 30-minute assay of distance moved (C) and time in the center (E) were computationally split into six segments with 5 minute per segment. The GW4064 treatment did not have effects on distance traveled and time spent in the center for each 5-minute segment in BTBR mice. The data are presented as the mean ± SEM. n = 10. **p < 0.01; ***p < 0.001.